Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution |
Stage![]() |
Project Objective | Details |
---|---|---|---|---|---|---|
COVID-19 | Adult Stem Cell | Small molecule therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | Embryonic Stem Cell | Biologic | USC |
![]() |
Pre-IND/IDE or Equivalent | |
Intestinal Disease, Neurological Disorders |
iPS Cell | Donor cell therapy | CHLA |
![]() |
Pre-IND/IDE or Equivalent | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Research Insights | |
Canavan Disease | iPS Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | CHORI |
![]() |
Regulated Lab Test, Ready for Validation | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML), Multiple Myeloma |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | iPS Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Brain Injury, hypoxic, ischemic | Adult Stem Cell | Donor cell therapy | Sanford-Burnham |
![]() |
Pre-IND/IDE or Equivalent | |
Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | Embryonic Stem Cell | Therapeutic Approach | UCSD |
![]() |
Development Candidate, Research Insights | |
Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | UCSF |
![]() |
Regulated Lab Test, Ready for Validation | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
IND | |
HIV/AIDS | Personalized cell therapy | COH |
![]() |
IND | ||
Parkinson's Disease | Adult Stem Cell | Gene-modified, donor cell therapy | UCSF |
![]() |
IND | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
IND | |
IPEX Syndrome, Immune Disease |
Vital Research Opportunity | Gene Therapy, cell free | Stanford |
![]() |
IND | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
IND | |
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Leukocyte Adhesion Deficiency |
Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | Lineage Cell |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Beta Thalassemia | Adult Stem Cell | Gene-modified, personalized cell therapy | Sangamo |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Type 1 diabetes | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Donor cell therapy | Celularity Inc |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | Angiocrine |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cystinosis, Kidney Failure |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 |